Mirae Asset Global Etfs Holdings Ltd. Collegium Pharmaceutical, Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 17,560 shares of COLL stock, worth $601,956. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,560
Previous 19,046
7.8%
Holding current value
$601,956
Previous $568,000
8.63%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding COLL
# of Institutions
241Shares Held
36.4MCall Options Held
52.5KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$199 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3.16MShares$108 Million2.15% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$90.5 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$77.1 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.58MShares$54.3 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.17B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...